TABLE 2.
Patient no. | Antibiotic resistance profilea | pI(s) |
bla gene typeb
|
PFGE result | ||
---|---|---|---|---|---|---|
CTX-M-9 | SHV | TEM | ||||
1 | GEN-TOB-CIP-SXT | 8.1, 8.2 | + | + | − | A |
2 | GEN-TOB-CIP-SXT | 8.2 | − | + | − | A |
3 | GEN-TOB-CIP-SXT | 8.1, 8.2 | + | + | − | A |
GEN-TOB-CIP-SXT | 8.1, 8.2 | + | + | − | A | |
4 | GEN-TOB-CIP-SXT | 5.4 | − | − | + | B |
5 | GEN-TOB-CIP-SXT | 8.2 | − | + | − | A |
6 | GEN-TOB-CIP-SXT | 8.1, 8.2 | + | + | − | A |
7 | GEN-TOB-CIP-SXT | 5.4 | − | − | + | B |
GEN, gentamicin; TOB, tobramycin; CIP, ciprofloxacin; SXT, trimethoprim-sulfamethoxazole.
TEM corresponds to a pI of 5.4. CTX-M9 corresponds to a pI of 8.1. SHV corresponds to a pI of 8.2.